This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Ghosh Shyamali: Innovator in Urotensin II Receptor Antagonists
Introduction
Ghosh Shyamali is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target Urotensin II receptor antagonists. His work is essential for advancing treatments for Urotensin-II mediated disorders.
Latest Patents
Ghosh holds a patent for "Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists." This invention is directed towards novel compounds that are useful in treating or ameliorating disorders mediated by Urotensin-II. The patent describes methods for preparing these compounds, as well as pharmaceutical compositions that utilize them for therapeutic purposes.
Career Highlights
Ghosh Shyamali is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions for complex medical conditions. With a total of 1 patent, he has established himself as a key figure in his area of expertise.
Collaborations
Some of Ghosh's notable coworkers include Diane K Luci and Bruce E Maryanoff. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical field.
Conclusion
Ghosh Shyamali's contributions to the development of Urotensin II receptor antagonists highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new treatments that can significantly impact patient outcomes.